NCT06231355 - Liposomal vs. Conventional Bupivacaine for Pain Control | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 21, 2024

Primary Completion Date

September 9, 2024

Study Completion Date

October 14, 2024

Conditions

Local AnestheticsAnalgesiaRegional BlockParavertebral Block

Interventions

DRUG

Performing paravertebral nerve block with lipo-bupivacaine

Paravertebral block is performed using liposomal bupivacaine.

DRUG

Performing paravertebral nerve block with bupivacaine

Paravertebral block is performed using bupivacaine.

Trial Locations (1)

Peking University First Hospital, Beijing

All Listed Sponsors

lead

Peking University First Hospital

OTHER